Recently, we reported that ABIN1 attenuates linear ubiquitin-mediated activation of NF-κB by degrading signaling protein complexes involved in the TLR signaling pathway (13), which implies that augmented linear ubiquitination is associated with SLE as well as SS. The gene discussed is NFKB1; the disease is systemic lupus erythematosus.